TY  - GEN
AU  - Huber,R M
AU  - Reck,M
AU  - Gosse,H
AU  - von Pawel,J
AU  - Mezger,J
AU  - Saal,J G
AU  - Kleinschmidt,R
AU  - Steppert,C
AU  - Steppling,H
TI  - Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer
SN  - 0903-1936
PY  - 2006///1109
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Small Cell
KW  - drug therapy
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Leukocyte Count
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Neoplasm Staging
KW  - Neutropenia
KW  - chemically induced
KW  - Neutrophils
KW  - drug effects
KW  - Organoplatinum Compounds
KW  - Platelet Count
KW  - Retreatment
KW  - Survival Rate
KW  - Topotecan
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1183/09031936.06.00015605
ER  -